Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities

Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are required to limit myocardial infarct (MI) size, prevent adverse left ventricular (LV) remodeling, and reduce the onset of heart failure following...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacol Ther
Hlavní autoři: Ong, Sang-Bing, Hernández-Reséndiz, Sauri, Crespo-Avilan, Gustavo E., Mukhametshina, Regina T., Kwek, Xiu-Yi, Cabrera-Fuentes, Hector A., Hausenloy, Derek J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Pergamon Press 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5981007/
https://ncbi.nlm.nih.gov/pubmed/29330085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.01.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky